Skip to main content
Veterinary Medicines

NICILAN 200 mg/50 mg tablets for dogs

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate

Product identification

Medicine name:
NICILAN 200 mg/50 mg tablets for dogs
Nicilan 200 mg + 50 mg Tabletka
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    200.00
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • box containing 240 tablets (40 blister)
  • box containing 120 tablets (20 blister)
  • box containing 60 tablets (10 blister)
  • box containing 12 tablets (2 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2033
Reference member state:
  • Spain
Procedure number:
  • ES/V/0155/002
Concerned member states:
  • Germany
  • Greece
  • Italy
  • Poland
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 5/04/2023
Download
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

English (PDF)
Published on: 5/04/2023
Download
Polish (PDF)
Published on: 4/02/2022

Labelling

English (PDF)
Published on: 5/04/2023
Download
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."